Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 83846-83-7
2. Ketanserintartrate
3. 3-(2-(4-(p-fluorobenzoyl)-1-piperidinyl)ethyl)-2,4(1h,3h)-quinazolinedione L-tartrate
4. Ketanserin (tartrate)
5. 2,3-dihydroxybutanedioic Acid;3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1h-quinazoline-2,4-dione
6. Ketanserin (+)-tartrate Salt
7. 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4[1h,3h]-quinazolinedione Tartrate
8. Smr000058867
9. Sr-01000002994
10. C22h22fn3o3.c4h6o6
11. Ketanserin Tartarate
12. Prestwick0_000392
13. Prestwick1_000392
14. Prestwick2_000392
15. Ketanserin Tartrate- Bio-x
16. Lopac0_001191
17. Mls000069367
18. Mls001333708
19. Schembl362930
20. Spbio_002524
21. Chembl1256709
22. Hms2234g22
23. Hms3263p03
24. Hms3267a11
25. Hms3369o05
26. Hms3414h11
27. Hms3678h09
28. Amy42112
29. Tox21_501191
30. Mfcd11864992
31. Akos024458689
32. Ccg-222495
33. Lp01191
34. Ncgc00016200-02
35. Ncgc00094444-01
36. Ncgc00261876-01
37. 84001-70-7
38. Bk164598
39. Ls-15143
40. Eu-0101191
41. S-006
42. R 41 468
43. Sr-01000002994-2
44. Sr-01000002994-4
45. 3-(2-(4-(4-fluorobenzoyl)piperidin-1-yl)ethyl)quinazoline-2,4(1h,3h)-dione (2r,3r)-2,3-dihydroxysuccinate
Molecular Weight | 545.5 g/mol |
---|---|
Molecular Formula | C26H28FN3O9 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 8 |
Exact Mass | 545.18095764 g/mol |
Monoisotopic Mass | 545.18095764 g/mol |
Topological Polar Surface Area | 185 Ų |
Heavy Atom Count | 39 |
Formal Charge | 0 |
Complexity | 761 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Global Sales Information
Market Place
ABOUT THIS PAGE
80
PharmaCompass offers a list of Ketanserin Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ketanserin Tartrate manufacturer or Ketanserin Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ketanserin Tartrate manufacturer or Ketanserin Tartrate supplier.
PharmaCompass also assists you with knowing the Ketanserin Tartrate API Price utilized in the formulation of products. Ketanserin Tartrate API Price is not always fixed or binding as the Ketanserin Tartrate Price is obtained through a variety of data sources. The Ketanserin Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ketanserin Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ketanserin Tartrate, including repackagers and relabelers. The FDA regulates Ketanserin Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ketanserin Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ketanserin Tartrate supplier is an individual or a company that provides Ketanserin Tartrate active pharmaceutical ingredient (API) or Ketanserin Tartrate finished formulations upon request. The Ketanserin Tartrate suppliers may include Ketanserin Tartrate API manufacturers, exporters, distributors and traders.
Ketanserin Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ketanserin Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ketanserin Tartrate GMP manufacturer or Ketanserin Tartrate GMP API supplier for your needs.
A Ketanserin Tartrate CoA (Certificate of Analysis) is a formal document that attests to Ketanserin Tartrate's compliance with Ketanserin Tartrate specifications and serves as a tool for batch-level quality control.
Ketanserin Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Ketanserin Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ketanserin Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ketanserin Tartrate EP), Ketanserin Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ketanserin Tartrate USP).